
Quanglong N. Truong
Examiner (ID: 17769, Phone: (571)270-0719 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 746 |
| Issued Applications | 510 |
| Pending Applications | 123 |
| Abandoned Applications | 141 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19316724
[patent_doc_number] => 20240238264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => INHIBITORS OF SARM1 NADASE ACTIVITY AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/406825
[patent_app_country] => US
[patent_app_date] => 2024-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -122
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18406825
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/406825 | INHIBITORS OF SARM1 NADASE ACTIVITY AND USES THEREOF | Jan 7, 2024 | Abandoned |
Array
(
[id] => 19456765
[patent_doc_number] => 12097233
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-09-24
[patent_title] => Composition for treating night blindness
[patent_app_type] => utility
[patent_app_number] => 18/545896
[patent_app_country] => US
[patent_app_date] => 2023-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2302
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18545896
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/545896 | Composition for treating night blindness | Dec 18, 2023 | Issued |
Array
(
[id] => 20057150
[patent_doc_number] => 20250195372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => EMULSION COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND SEMI-CRYSTALLINE POLYMER
[patent_app_type] => utility
[patent_app_number] => 18/543702
[patent_app_country] => US
[patent_app_date] => 2023-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18543702
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/543702 | EMULSION COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND SEMI-CRYSTALLINE POLYMER | Dec 17, 2023 | Pending |
Array
(
[id] => 19784312
[patent_doc_number] => 20250057991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => NANOMATERIAL COMPOSITION AND USE OF THE SAME FOR MAGNETIC FIELD-INDUCED ELECTRICAL STIMULATION OF CELLS
[patent_app_type] => utility
[patent_app_number] => 18/540750
[patent_app_country] => US
[patent_app_date] => 2023-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18540750
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/540750 | NANOMATERIAL COMPOSITION AND USE OF THE SAME FOR MAGNETIC FIELD-INDUCED ELECTRICAL STIMULATION OF CELLS | Dec 13, 2023 | Pending |
Array
(
[id] => 19263476
[patent_doc_number] => 20240207173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => SALT ACTIVATABLE DISSOLVABLE POLYMERIC EYE INSERTS AND KIT OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/536388
[patent_app_country] => US
[patent_app_date] => 2023-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18536388
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/536388 | SALT ACTIVATABLE DISSOLVABLE POLYMERIC EYE INSERTS AND KIT OF THE SAME | Dec 11, 2023 | Pending |
Array
(
[id] => 19930406
[patent_doc_number] => 12303599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Self-emulsifying cannabidiol formulations
[patent_app_type] => utility
[patent_app_number] => 18/534301
[patent_app_country] => US
[patent_app_date] => 2023-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 295
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18534301
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/534301 | Self-emulsifying cannabidiol formulations | Dec 7, 2023 | Issued |
Array
(
[id] => 19246647
[patent_doc_number] => 20240197631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => ATOMOXETINE ORAL SOLUTION
[patent_app_type] => utility
[patent_app_number] => 18/532721
[patent_app_country] => US
[patent_app_date] => 2023-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18532721
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/532721 | Atomoxetine oral solution | Dec 6, 2023 | Issued |
Array
(
[id] => 19049191
[patent_doc_number] => 20240091160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => PHARMACEUTICAL COMPOSTION CONTAINING ACETOMINOPHEN AND IBUPROFEN
[patent_app_type] => utility
[patent_app_number] => 18/518202
[patent_app_country] => US
[patent_app_date] => 2023-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18518202
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/518202 | Pharmaceutical compostion containing acetominophen and ibuprofen | Nov 21, 2023 | Issued |
Array
(
[id] => 19700074
[patent_doc_number] => 12194073
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-01-14
[patent_title] => Method of arthropod egress
[patent_app_type] => utility
[patent_app_number] => 18/445610
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4672
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18445610
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/445610 | Method of arthropod egress | Nov 16, 2023 | Issued |
Array
(
[id] => 19140327
[patent_doc_number] => 20240139103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => Devices and Methods for Delivering Methane Inhibiting Compounds to Animals
[patent_app_type] => utility
[patent_app_number] => 18/498661
[patent_app_country] => US
[patent_app_date] => 2023-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18498661
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/498661 | Devices and methods for delivering methane inhibiting compounds to animals | Oct 30, 2023 | Issued |
Array
(
[id] => 18986391
[patent_doc_number] => 20240058360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => TREATMENT OF OCULAR INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 18/383993
[patent_app_country] => US
[patent_app_date] => 2023-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18383993
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/383993 | Treatment of ocular inflammation | Oct 25, 2023 | Issued |
Array
(
[id] => 18986393
[patent_doc_number] => 20240058362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => TREATMENT OF DIABETIC RETINOPATHY
[patent_app_type] => utility
[patent_app_number] => 18/384000
[patent_app_country] => US
[patent_app_date] => 2023-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18384000
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/384000 | Treatment of diabetic retinopathy | Oct 25, 2023 | Issued |
Array
(
[id] => 18986390
[patent_doc_number] => 20240058359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => STABILIZED DEXAMETHASONE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/383991
[patent_app_country] => US
[patent_app_date] => 2023-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18383991
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/383991 | Stabilized dexamethasone compositions | Oct 25, 2023 | Issued |
Array
(
[id] => 19297809
[patent_doc_number] => 20240226375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => FLOWABLE ACELLULAR TISSUE MATRIX PRODUCTS AND METHODS OF PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/380472
[patent_app_country] => US
[patent_app_date] => 2023-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18380472
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/380472 | FLOWABLE ACELLULAR TISSUE MATRIX PRODUCTS AND METHODS OF PRODUCTION | Oct 15, 2023 | Abandoned |
Array
(
[id] => 20886110
[patent_doc_number] => 20260223848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-08-06
[patent_title] => METHOD OF INCREASING SUGAR PRODUCTION FROM SUGARCANE
[patent_app_type] => utility
[patent_app_number] => 18/554691
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554691
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554691 | METHOD OF INCREASING SUGAR PRODUCTION FROM SUGARCANE | Oct 9, 2023 | Pending |
Array
(
[id] => 19150131
[patent_doc_number] => 11975021
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-05-07
[patent_title] => Topical compositions comprising emulsified povidone iodine solutions and methods of preparation
[patent_app_type] => utility
[patent_app_number] => 18/378069
[patent_app_country] => US
[patent_app_date] => 2023-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 4744
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18378069
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/378069 | Topical compositions comprising emulsified povidone iodine solutions and methods of preparation | Oct 8, 2023 | Issued |
Array
(
[id] => 19081848
[patent_doc_number] => 20240108649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => GUMMY DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 18/475416
[patent_app_country] => US
[patent_app_date] => 2023-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18475416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/475416 | GUMMY DOSAGE FORMS | Sep 26, 2023 | Pending |
Array
(
[id] => 19730153
[patent_doc_number] => 12208139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Controlled drug release from electrospun fibers
[patent_app_type] => utility
[patent_app_number] => 18/372165
[patent_app_country] => US
[patent_app_date] => 2023-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2078
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18372165
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/372165 | Controlled drug release from electrospun fibers | Sep 24, 2023 | Issued |
Array
(
[id] => 18893630
[patent_doc_number] => 20240009115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => DRUG DELIVERY SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/472426
[patent_app_country] => US
[patent_app_date] => 2023-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18472426
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/472426 | DRUG DELIVERY SYSTEMS | Sep 21, 2023 | Abandoned |
Array
(
[id] => 18986256
[patent_doc_number] => 20240058225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => FILM-FORMING COMPOSITION CONTAINING SURFACTANT OR SURFACTANT AND SALT AS WHITENING AGENT
[patent_app_type] => utility
[patent_app_number] => 18/371163
[patent_app_country] => US
[patent_app_date] => 2023-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18371163
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/371163 | Film-forming composition containing surfactant or surfactant and salt as whitening agent | Sep 20, 2023 | Issued |